TAKEDA PHARMACEUTICAL CO LTD - 14 May 2021 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: 10%+ Owner
Signature: /s/ Amit Singh, Senior Vice President and Head of Treasury of Takeda Pharmaceutical Company Limited
Issuer symbol: PHAT
Transactions as of: 14 May 2021
Net transactions value: -$3,500
Form type: 4
Filing time: 18 May 2021, 06:02:27 UTC
Previous filing: 14 May 2021
Next filing: 24 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Sale	$3,500	-100	-0.01%	$35.00	1,029,883	14 May 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 2, 2021.